225
Views
36
CrossRef citations to date
0
Altmetric
Original Article

Treatment of Cancer with Mushroom Products

Pages 533-537 | Published online: 07 Aug 2010

  • Sikora K. The future of cancer care. Pharmacia Lecture at The Royal Society, London, April 2001. Available from Prof. Karol Sikora, 79 Harley Street, London W1G 8PZ, UK.
  • Fekuda K, Straus SE, Hickie I, et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med 1994; 121:953-59.
  • Vojdani A. Natural Killer Cytotoxicity, Apoptosis and Cell Cycle in Human Health and Disease. Beverly Hills, CA: Immunosciences Lab., Inc., 1997; p 15.
  • Monro JM. Coriolus: the use of the medicinal mushroom Coriolus MRL® as an immunotherapeutic agent in the treatment of patients with chronic fatigue syndrome. (Submitted for publication 2004 to Journal of Integrative Medicine.)
  • Smith JE, Rowan NK, Sullivan R. Medicinal Mushrooms: Their Therapeutic Properties and Current Medical Usage with Special Emphasis on Cancer Treatments. London: Cancer Research UK, 2000; p 220. http://sci.cancer researchuk.org/labs/med_mush/med_mush.html
  • Ikekawa T. Beneficial effects of edible and medicinal mushrooms on health care. Int J Med Mushrooms 2001; 3:291-98.
  • Alberts B, Bray D, Lewis J, et al. Molecular Biology of the Cell. 3rd ed. New York: Garland Publishing, 1994; p 17.
  • Eiben GL, Da Silva DM, Fausch SC, et al. Cervical cancer vaccines: recent advances in HPV research. Viral Immunol 2003; 16:111-21.
  • Bosch FX, Manos MM, Muñoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 1995; 87:796-802.
  • de-The G, Geser A, Day NE, et al. Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study. Nature 1978; 274:756-61.
  • British National Formulary. 45th ed. Sec 8: Malignant disease and immunosuppression. London: British Medical Association and Royal Pharmaceutical Society of Great Britain, 2003; pp 407-38.
  • Cheek AO, Vonier PM, Oberdorster E, et al. Environmental signaling: a biological context for endocrine disruption. Environ Health Perspect 1998; 106(Suppl 1):5-10.
  • Crisp TM, Clegg ED, Cooper RL, et al. Environmental endocrine disruption: an effects assessment and analysis. Environ Health Perspect 1998; 106(Suppl 1):11-56.
  • World Health Organization (WHO) Study Group on Diet, Nutrition and Non-Communicable Diseases. Diet, Nutrition and the Prevention of Chronic Diseases. Geneva: WHO, 1990; pp 67, 69.
  • Alter MJ. Protecting future generations through immunization against hepatitis B. Ann Intern Med 2001; 135: 835-36.
  • Mueller N, Evans A, Harris NL, et al. Hodgkin's disease and Epstein-Barr virus: altered antibody pattern before diagnosis. N Engl J Med 1989; 16:689-95.
  • Bukin YV, Draudin-Krylenko VA, Levchuk AA, et al. The effect of high doses of folic acid on the overexpression of ornithine decarboxylase and S-adenosylmethionine content in human colon adenomatous polyps. Ann NY Acad Sci 2001; 952:175-76.
  • Holmes GP, Kaplan JE, Gantz NM, et al. Chronic fatigue syndrome: a working case definition. Ann Intern Med 1988; 108:387-89.
  • Pischinger A. Matrix and Matrix Regulation: Basis for a Holistic Theory in Medicine. Brussels, Belgium: Editions Haug International, 1991.
  • Roitt IM. Essential Immunology. 9th ed. Oxford: Blackwell Science, 1997; p 34.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.